Kondrosarkoma Dokter Terbaik di Israel - TOP-7 dokter

Pemimpin dalam perawatan sarkoma dengan pengalaman lebih dari 25 tahun mengepalai Unit Onkologi Jaringan Lunak dan Tulang di Sourasky Medical Center.

• Menyelesaikan pelatihan Fellowship di Institut Gustave Roussy di Paris, pusat sarkoma ternama di dunia
• Anggota fakultas dari kelompok Sarkoma European Society of Medical Oncology (ESMO)
• Telah memublikasikan banyak karya tentang onkologi ortopedi dan protokol pengobatan

Direktur hematologi onkologi anak di Sourasky Medical Center – spesialis dalam pengobatan kanker tulang pada anak-anak.

• Ahli dalam pengobatan sarkoma pada anak-anak
• Menjalani pelatihan di Rizzoli Orthopaedic Institute – pusat terkemuka di dunia
• Mengoordinasikan pengobatan kanker tulang dengan tim onkologi-ortopedi
• Anggota ISPHO – Asosiasi hemato-onkologi anak Israel

Dr. Amir adalah spesialis dalam bedah penyelamatan anggota tubuh untuk kanker tulang dan jaringan lunak di Sourasky Medical Center Israel (Ichilov).

• Menjalani pelatihan fellowship dalam onkologi ortopedi di National Cancer Institute AS dan University of Toronto
• Anggota aktif dari American Musculoskeletal Tumor Society (MSTS) dan International Society of Limb Salvage (ISOLS)
• Pemenang berbagai penghargaan, termasuk Tannenbaum Grant untuk keunggulan dalam onkologi bedah
• Berfokus pada sarkoma, dengan keahlian dalam kasus-kasus kompleks yang memerlukan teknik rekonstruksi

Memimpin departemen yang didedikasikan untuk lesi tulang metastatik di Ichilov Medical Center – salah satu rumah sakit terbesar di Israel.

• Berespesialisasi khusus dalam ortopedi onkologi, menangani kanker tulang.
• Menyelesaikan magang klinis tingkat lanjut di Israel dan Amerika Serikat.
• Memegang posisi akademik senior sebagai Profesor di Universitas Tel Aviv.
• Menempuh pendidikan di Universitas Ibrani Yerusalem yang bergengsi.

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.